SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-302156
Filing Date
2023-12-22
Accepted
2023-12-22 16:30:58
Documents
18
Period of Report
2023-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d70426d8k.htm   iXBRL 8-K 35367
2 EX-1.1 d70426dex11.htm EX-1.1 156476
3 EX-4.1 d70426dex41.htm EX-4.1 72497
4 EX-5.1 d70426dex51.htm EX-5.1 7416
5 EX-10.1 d70426dex101.htm EX-10.1 198328
6 EX-10.2 d70426dex102.htm EX-10.2 97903
10 GRAPHIC g70426dsp2.jpg GRAPHIC 4262
  Complete submission text file 0001193125-23-302156.txt   859878

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sttk-20231221.xsd EX-101.SCH 2866
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20231221_lab.xml EX-101.LAB 18738
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20231221_pre.xml EX-101.PRE 11718
12 EXTRACTED XBRL INSTANCE DOCUMENT d70426d8k_htm.xml XML 3463
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

IRS No.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 231510280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)